Published :
Tables : 54
Figures : 52
Category : Healthcare
No. of Pages : 220
Report Code : HC-U3337
Radiation Toxicity Treatment Market is predicted to value over USD 5 billion by 2028 end with a CAGR of over 5.2% during the forecast period 2022 to 2028. The rising installations of radiation therapy machines for treating different cancer types has increased radiation toxicity in patients. Furthermore, favourable reimbursements and government policies for cancer treatments has made radiation therapy ore accessible, thereby boosting the radiation toxicity treatment market growth. Moreover, the increased acceptance of factors that are colony stimulated shall boost the proliferation of the market. Additionally, parameters like positive product reviews, financials have bolstered the augmentation of the market. According to the American cancer Society, over 17,35,000 cancer cases were registered in 2018. Such a high prevalence of cancer shall increase the number of patients getting diagnosed with radiation toxicity, thereby propelling the market growth. Radiation toxicity is primarily caused by exposure to radiations in nuclear power plants either intentionally or accidently. With many countries investing in nuclear energy, there has been a rise in the number of nuclear plants, increasing the chances of people getting toxified by radiations, resulting in the augmentation of the market. Market Segmentation: By Product • Colony Stimulating Factors • Potassium Iodide • Prussian Blue • Diethylenetriamine Pentaacetic Acid • Others By Indication • Acute Radiation Syndrome o Bone Marrow Syndrome (Hematopoietic) o Gastrointestinal Syndrome (GI) o Cardiovascular (CV) o Central Nervous System (CNS) Syndrome • Chronic Radiation Syndrome By Radiation • Ionizing Radiation o Alpha Radiation o Beta Radiation o Gamma Radiation • Non-Ionizing Radiation By End User • Hospitals • Research & Academic Institutes By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa The market is diversified into product, by indication, by radiation, by end user and region. The product segment is fragmented into colony stimulating factors, potassium iodide, prussian blue, diethylenetriamine pentaacetic acid. The end user segment is classified into hospitals, research & academic institutes. Regional Analysis: The North America region is predicted to hold the largest radiation toxicity treatment market share during the forecast period owing to increased use of PET and single-photon emission computed tomography scanning machines at diagnostic centres. Furthermore, favourable health coverage policies and stringent regulations have boosted the market growth in the region. The Asia pacific region, on the other hand, is predicted to grow at a substantial rate during the forecast period. Competitive Landscape: Some of the key market players are Aeolus Pharmaceuticals, Cantex Pharmaceuticals, Gamida Cell Ltd., Nanotherpautics Inc., NeoStem Inc., Cleveland BioLabs Inc., Osiris Therapeutics Inc., Amgen Inc., Partner Therapeutics, Inc., Novartis AG. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global radiation toxicity treatment market by product, by indication, by radiation, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
The rising installations of radiation therapy machines for treating different cancer types has increased radiation toxicity in patients. Furthermore, favourable reimbursements and government policies for cancer treatments has made radiation therapy ore accessible, thereby boosting the radiation toxicity treatment market growth. Moreover, the increased acceptance of factors that are colony stimulated shall boost the proliferation of the market. Additionally, parameters like positive product reviews, financials have bolstered the augmentation of the market. According to the American cancer Society, over 17,35,000 cancer cases were registered in 2018. Such a high prevalence of cancer shall increase the number of patients getting diagnosed with radiation toxicity, thereby propelling the market growth. Radiation toxicity is primarily caused by exposure to radiations in nuclear power plants either intentionally or accidently. With many countries investing in nuclear energy, there has been a rise in the number of nuclear plants, increasing the chances of people getting toxified by radiations, resulting in the augmentation of the market.
Market Segmentation:
By Product • Colony Stimulating Factors • Potassium Iodide • Prussian Blue • Diethylenetriamine Pentaacetic Acid • Others By Indication
• Acute Radiation Syndrome o Bone Marrow Syndrome (Hematopoietic) o Gastrointestinal Syndrome (GI) o Cardiovascular (CV) o Central Nervous System (CNS) Syndrome • Chronic Radiation Syndrome
By Radiation
• Ionizing Radiation o Alpha Radiation o Beta Radiation o Gamma Radiation • Non-Ionizing Radiation
By End User • Hospitals • Research & Academic Institutes By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
The market is diversified into product, by indication, by radiation, by end user and region. The product segment is fragmented into colony stimulating factors, potassium iodide, prussian blue, diethylenetriamine pentaacetic acid. The end user segment is classified into hospitals, research & academic institutes.
Regional Analysis:
The North America region is predicted to hold the largest radiation toxicity treatment market share during the forecast period owing to increased use of PET and single-photon emission computed tomography scanning machines at diagnostic centres. Furthermore, favourable health coverage policies and stringent regulations have boosted the market growth in the region. The Asia pacific region, on the other hand, is predicted to grow at a substantial rate during the forecast period.
Competitive Landscape:
Some of the key market players are Aeolus Pharmaceuticals, Cantex Pharmaceuticals, Gamida Cell Ltd., Nanotherpautics Inc., NeoStem Inc., Cleveland BioLabs Inc., Osiris Therapeutics Inc., Amgen Inc., Partner Therapeutics, Inc., Novartis AG.
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global radiation toxicity treatment market by product, by indication, by radiation, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Radiation Toxicity Treatment Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Radiation Toxicity Treatment Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Radiation Toxicity Treatment Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Radiation Toxicity Treatment Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Colony Stimulating Factors 7.2 Potassium Iodide 7.3 Prussian Blue 7.4 Diethylenetriamine Pentaacetic Acid 7.5 Others 8. Radiation Toxicity Treatment Market, By Indication Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Acute Radiation Syndrome 8.1.1. Bone Marrow Syndrome (Hematopoietic) 8.1.2. Gastrointestinal Syndrome (GI) 8.1.3. Cardiovascular (CV) 8.1.4. Central Nervous System (CNS) Syndrome 8.2. Chronic Radiation Syndrome 9. Radiation Toxicity Treatment Market, By Radiation Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Ionizing Radiation 9.1.1. Alpha Radiation 9.1.2. Beta Radiation 9.1.3. Gamma Radiation 9.2. Non-Ionizing Radiation 10. Radiation Toxicity Treatment Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Hospitals 10.2. Clinics 10.3. Pharmacies and drug stores 10.4. Diagnostic Centers 10.5. Research and academic institutes 10.6. Others 11. North America Radiation Toxicity Treatment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028 12. Latin America Radiation Toxicity Treatment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028 13. Europe Radiation Toxicity Treatment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028 14. Asia Pacific Radiation Toxicity Treatment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028 16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. Aeolus Pharmaceuticals 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Cantex Pharmaceuticals 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Gamida Cell Ltd. 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Nanotherpautics Inc. 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. NeoStem Inc. 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. Cleveland BioLabs Inc. 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. Osiris Therapeutics Inc. 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Amgen Inc. 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Partner Therapeutics, Inc. 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10.Novartis AG 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations 19. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Radiation Toxicity Treatment Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Radiation Toxicity Treatment Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Radiation Toxicity Treatment Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Radiation Toxicity Treatment Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Colony Stimulating Factors 7.2 Potassium Iodide 7.3 Prussian Blue 7.4 Diethylenetriamine Pentaacetic Acid 7.5 Others
8. Radiation Toxicity Treatment Market, By Indication Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Acute Radiation Syndrome 8.1.1. Bone Marrow Syndrome (Hematopoietic) 8.1.2. Gastrointestinal Syndrome (GI) 8.1.3. Cardiovascular (CV) 8.1.4. Central Nervous System (CNS) Syndrome 8.2. Chronic Radiation Syndrome
9. Radiation Toxicity Treatment Market, By Radiation Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Ionizing Radiation 9.1.1. Alpha Radiation 9.1.2. Beta Radiation 9.1.3. Gamma Radiation 9.2. Non-Ionizing Radiation
10. Radiation Toxicity Treatment Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Hospitals 10.2. Clinics 10.3. Pharmacies and drug stores 10.4. Diagnostic Centers 10.5. Research and academic institutes 10.6. Others
11. North America Radiation Toxicity Treatment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028
12. Latin America Radiation Toxicity Treatment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028
13. Europe Radiation Toxicity Treatment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028
14. Asia Pacific Radiation Toxicity Treatment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028
16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. Aeolus Pharmaceuticals 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Cantex Pharmaceuticals 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Gamida Cell Ltd. 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Nanotherpautics Inc. 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. NeoStem Inc. 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. Cleveland BioLabs Inc. 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. Osiris Therapeutics Inc. 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Amgen Inc. 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Partner Therapeutics, Inc. 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10.Novartis AG 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview
18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics